Ying Xu

发表

A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis

Xiaowei Liu, Q. Lei, Lidan Zhang, 2015 .

BRD4 inhibition sensitizes aggressive non-Hodgkin lymphomas to PI3Kδ inhibitors by suppressing PI3K reactivation and c-MYC expression.

Yong Xia, Yongxia Zhu, Ningyu Wang, 2021, American journal of cancer research.

Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N'-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo.

Q. Lei, Lidan Zhang, Yong Xia, 2015, Bioorganic & medicinal chemistry.

Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis.

Yong Xia, Yongxia Zhu, Ying Xu, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.

Yuquan Wei, Lidan Zhang, Yong Xia, 2013, Bioorganic & medicinal chemistry letters.

Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor.

Ningyu Wang, Ying Xu, Weiqiong Zuo, 2021, European journal of medicinal chemistry.

LINC01303 functions as a competing endogenous RNA to regulate EZH2 expression by sponging miR‐101‐3p in gastric cancer

Ying Xu, Yan Xie, Chen Cao, 2019, Journal of cellular and molecular medicine.

Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site.

Yong Xia, Ying Xu, Luoting Yu, 2020, Bioorganic chemistry.

Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors.

Ningyu Wang, Ying Xu, Luoting Yu, 2019, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.

Yongxia Zhu, Ningyu Wang, Ying Xu, 2020, European journal of medicinal chemistry.

Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agents.

Yuquan Wei, Hong Tang, Q. Lei, 2015, Journal of medicinal chemistry.

Discovery and structure-activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors.

Yuquan Wei, Sheng-yong Yang, Lidan Zhang, 2014, Bioorganic & medicinal chemistry letters.

The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathways.

Ying Xu, Sheng-Xiang Lv, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR‐377 to induce E2F3 expression

Ying Xu, Junhui Zhang, Chen Cao, 2020, Journal of cellular and molecular medicine.

Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors

Lidan Zhang, Xuejiao Song, Ningyu Wang, 2015 .

Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer

Ying Xu, Qing Zhu, 2023, International journal of molecular sciences.

Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.

Q. Lei, Xuejiao Song, Ying Xu, 2019, Cancer letters.

Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality

Xuejiao Song, Ningyu Wang, Ying Xu, 2020, Molecular Cancer Therapeutics.

Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.

Yongxia Zhu, Ningyu Wang, Ying Xu, 2020, Bioorganic chemistry.

A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity

Q. Lei, Lidan Zhang, Xuejiao Song, 2023, Heliyon.

Design, Synthesis and Structure-Activity Relationship Study of Piperazinone-Containing Thieno[3,2-d]pyrimidine Derivatives as New PI3Kδ Inhibitors.

Yongxia Zhu, Ningyu Wang, Ying Xu, 2020, Bioorganic & medicinal chemistry letters.